•
Sep 30, 2021

Solid Biosciences Q3 2021 Earnings Report

Total Revenue
$3.54M
EPS
-$2.4
Previous year: -$6.6
-63.6%
Cash and Equivalents
$110M
Previous year: $24.8M
+342.3%
Free Cash Flow
-$18.7M
Total Assets
$249M

Solid Biosciences

Solid Biosciences